ACETO Completes the Sale of Rising Pharmaceuticals

PORT WASHINGTON, N.Y., April 22, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has completed the previously disclosed sale of the assets of Rising Pharmaceuticals and Rising’s subsidiaries to Shore Suven Pharma, Inc.

Additional information about Aceto’s Chapter 11 cases can be found at http://cases.primeclerk.com/Aceto and by calling 844-216-7718, a toll-free number for callers in the U.S. and Canada, or 347-761-3238, for international callers.

About ACETO

ACETO Corporation, incorporated in 1947, is focused on the global marketing, sale and distribution of Human Health products (finished dosage form generics and nutraceutical products), Pharmaceutical Ingredients (pharmaceutical intermediates and active pharmaceutical ingredients) and Performance Chemicals (specialty chemicals and agricultural protection products). With business operations in nine countries, ACETO distributes over 1,100 chemical compounds used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. ACETO's global operations, including a staff of 25 in China and 12 in India, are distinctive in the industry and enable its worldwide sourcing and regulatory capabilities.

Company Contact: Jody BurfeningCommunications Consultant [email protected](212) 838-3777

You May Also Be Interested In

• Additional Information on the Ehrmann Family Increasing Its Equity Stake in Artprice by Artmarket as Part of Artprice's "AI-First" Transformation
• pixelgrinder Announces Second Full-Length Album “White Mask” for September 25 Release
• World's First Autonomous Humanoid Tennis Match: GALBOT Robots Complete 100+ Consecutive Rallies